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Populärvetenskaplig 
sammanfattning 
Proteiner är inte bara ett näringsämne i mat. De är biologiska makromolekyler 
som utgör en essentiell del av allt liv vi känner till. Exempelvis styr de många 
biokemiska processer genom att snabba på vissa reaktioner mellan olika 
molekyler, och de utgör ett viktigt byggmaterial i och utanför celler såsom i 
cellskelett och i bindväv. För att allt ska fungera är det viktigt att proteiner inte 
veckar sig fel och inte klumpar ihop sig med varandra på onormala sätt. Om det 
händer kan det leda till olika sjukdomstillstånd. Det finns en särskild typ av 
proteinklumpar som kallas amyloider. De utgörs av mikroskopiska trådar som 
kan ansamlas i eller utanför celler. Amyloider förekommer exempelvis i samband 
med sjukdomar som bryter ner hjärnan, såsom Alzheimers och Parkinsons 
sjukdom. I takt med att folk lever längre blir det viktigare att förstå dessa 
sjukdomar, eftersom de ofta är kopplade till hög ålder. Den här avhandlingen är 
ett bidrag till den grundforskning som försöker förstå amyloidbildning och dess 
möjliga samband med olika sjukdomstillstånd. Snarare än att studera 
amyloidbildning i levande celler har jag framförallt studerat ett kort 
proteinfragment, en peptid, i relativt enkla provlösningar som ett modellsystem 
för amyloider. På det viset kan beteenden och mekanismer lättare förstås från ett 
fysikaliskt perspektiv. Peptiden är ett 11 aminosyror långt fragment av proteinet 
alfa-synuklein, som är involverat i Parkinsons sjukdom. 
Proteiner är inte den enda typen av biomolekyler. En annan stor grupp är olika 
typer av fettmolekyler, så kallade lipider, som till exempel bildar membran som 
omger alla levande celler. I exempelvis nervsystemet är lipider en viktig del i så 
kallade axoner, dendriter och synapser som utgör grunden för all nervaktivitet. 
Man tror att bildandet av amyloider, liksom bildandet av lipidstrukturer, till stor 
del drivs av att undvika kontakt med vatten. Därför är det också sannolikt att 
amyloider och lipider kan samaggregera med varandra, vilket redan har 
observerats experimentellt i vissa fall. Samaggregering eller andra processer som 
stör normala lipidstrukturer är en möjlig mekanism som kan förklara hur 
bildandet av amyloider kan leda till sjukdomstillstånd. I den här avhandlingen har 
jag fokuserat just på växelverkan mellan amyloider och lipider. 
Sammanfattningsvis kan man säga att provlösningens pH, hur sur eller basisk den 
är, visade sig vara användbart för att styra modellpeptidens amyloidbildning. 
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Amyloidtrådarna som bildas av peptiden kan beskrivas som små och väldigt 
avlånga kristaller. Vad gäller växelverkan med lipider så fann vi att lipiderna har 
en stark tendens att fastna på amyloidtrådarna, och därmed att de bildar en sorts 
samaggregat på stora längdskalor. På små längdskalor, i storleksordningen några 
få nanometer, så verkar det dock som att majoriteten av amyloidtrådarna och 
lipiderna fortfarande behåller sina normala separata strukturer, i alla fall när 
lipiderna är så kallade fosfolipider. Vi fann också att närvaron av lipider kraftigt 
kan hämma modellpeptidens amyloidbildning, även med väldigt små mängder 
lipid. Att lipider fastnar på amyloidtrådarna kan i sig vara en mekanism som leder 
till skada på celler, eftersom det exempelvis kan störa det normala flödet och 
bildandet av olika lipidstrukturer i cellerna. Genom att jämföra resultaten från 
modellsystemet jag har studerat med resultat för andra proteiner och peptider så 
kan likheter och skillnader mellan olika amyloidsystem identifieras. Det kan till 
exempel hjälpa framtida forskare att veta vilka aspekter som är särskilt värdefulla 
att fokusera på för att förstå just de säregenskaper och mekanismer som 
karakteriserar en viss typ av amyloidbildning. 
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1 
Prologue 
In the work for this thesis a short model peptide (NACore) has been used to study 
the phenomenon of amyloid formation and amyloid-lipid interaction. The aim has 
been to contribute to physicochemical knowledge and understanding of amyloids. 
Below is a summary of the main findings in four short points. 
 
1. The peptide readily forms amyloid fibrils in vitro and the fibrillation can be 
controlled by pH. 
 
2. The fibrillation of the peptide is a crystallization process rather than just 
aggregation. 
 
3. The amyloid fibrils and phospholipids co-aggregate on the aggregate level but 
remain mostly segregated on molecular length scales. 
 
4. The presence of even very small amounts of lipids can substantially inhibit the 
fibrillation of the peptide. 
 
2 
  
3 
1. Introduction 
Amyloids are a very popular research topic nowadays. Much work is focused on 
the medical and clinical aspects of amyloids because they are associated with 
many diseases [1,2]. The work for this thesis is not directly applicable in that 
context. Rather, it is focused on the underlying physical chemistry of amyloids. 
There are a lot of things we still do not understand about this topic due to the 
complexity of biology and physiology. The use of model systems, such as a short 
peptide and simple model lipids as in the work for this thesis, is a tool to provide 
a better understanding of the amyloid phenomenon. That is because some of the 
complications in real biological systems are avoided. Once the model systems 
have been understood, more complexities can be added in a gradual manner until 
a complete picture has been reached. 
Below, some of the background topics for this thesis will be introduced. In 
chapter 2 the main experimental methods used will be described, and in chapter 
3 the main experimental results will be summarized and discussed. 
1.1 Proteins and peptides 
A typical protein is a small particle with a diameter of a few nanometers. A human 
cell contains of the order of 1010 protein particles [3], roughly the same as the 
number of people on Earth. A typical bacterium, which is much smaller than a 
human cell, contains a few million protein particles [3]. The activities of the 
proteins direct many of the physical and chemical processes of life. From a more 
chemical perspective, proteins are biopolymers made of peptide backbones on 
which side groups of various chemical compositions are attached. The units along 
the backbones are called amino acid residues because they are formed by joining 
amino acids together. In total there are 20 amino acid from which natural proteins 
are typically created [4,5]. Which kinds of proteins, as well as where and when 
they are synthesized, is determined by the genetic code stored in DNA. For 
protein synthesis to occur, a region of DNA is first transcribed to RNA in the 
form of so-called messenger RNA (mRNA). The mRNA then comes into contact 
with a ribosome, which translates it into a string of amino acid residues. As the 
amino acids are stitched together, the protein is formed [5]. 
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When a protein is present in an aqueous environment such as inside a cell, it 
usually folds up into a compact shape, due primarily to hydrophobic interactions 
[6]. However, in the last decades some proteins have been found to remain 
partially or fully disordered in solution. These are so-called intrinsically 
disordered proteins [7]. The detailed chemical structure of the side groups along 
the peptide backbone of a protein determines how it folds, because the side groups 
of the protein introduce various geometric and chemical constraints. There are 
only some folds for which various hydrophobic patches and other features are 
matched up in a thermodynamically stable way [6]. Inside a protein, two kinds of 
local protein structures are very common. These are Į-helices and ȕ-strands. In 
between these structures the peptide backbone typically adopts more disordered 
structures. Several ȕ-strands can be stacked next to each other to form ȕ-sheets. 
The sequence of Į-helices, ȕ-strands, and other local folds along the peptide 
backbone is called the secondary structure of a protein. The overall 3D fold of a 
protein is called the tertiary structure, whereas the sequence of amino acid 
residues that makes up the protein is called the primary structure [4,5] (Figure 
1.1). The structure and chemical nature of proteins are what give them their 
properties in the biological environment. In the case of enzymes, which facilitate 
chemical reactions through catalysis, a so-called active site with special 
geometric and chemical features has evolved through natural selection to promote 
a certain chemical reaction [4,5]. Other proteins do not promote chemical 
reactions, but act as structural components of cells, or for example take part in 
signaling pathways. If the proteins for some reason do not fold properly, or 
aggregate with each other in an abnormal way, the biological function might be 
compromised, and this can lead to diseases in the organism [1]. 
The distinction between proteins and peptides is rather fuzzy. One way to define 
them is simply by the length of the polymer, where proteins (also referred to as 
polypeptides) are very long peptides, although no clear cutoff size exists [8]. For 
this thesis, a short 11 amino acid residue peptide has been used in the 
experiments. This peptide is named NACore [9,10] and it is a fragment of the so-
called non-amyloid-ȕ component (NAC) of the protein Į-synuclein [11,12]. Į-
Synuclein is normally found in neural tissues. The normal function of this protein 
is still not fully understood, but it is believed to be involved in synaptic membrane 
functions in neurons [13]. There are several variants of synucleins (Į-, ȕ-, and Ȗ-
) and this group of proteins was initially named in 1988, when it was found co-
localized with the nucleus in neural cells [13-15]. In Parkinson’s disease, special 
aggregates of Į-synuclein are found in deposits called Lewy bodies inside 
neurons [16-18]. The NAC fragment of Į-synuclein can also be found aggregated 
in patients with Alzheimer’s disease, together with other proteins called amyloid-
ȕ and tau [13]. That is why it is called “NAC”. 
5 
 
Figure 1.1. Example of a protein structure. The figure shows the structure of the enzyme lysozyme, which was one 
of the earliest protein structures to be determined in detail. The primary structure is the sequence of amino acid 
residues along the peptide backbone, represented by letters. The secondary structure is the distribution of local 
folds such as Į-helices (blue coils) and ȕ-sheets made of ȕ-strands (yellow arrows). The tertiary structure is the 
overall 3D shape of the protein. PDB ID: 2LYZ, rendered with UCSF Chimera [19]. 
1.2 Amyloids 
Amyloids are made up of very long inter-molecular ȕ-sheets that are stacked 
together, giving rise to fibrils [1,2,20] (Figure 1.2). Both full-length proteins and 
short peptides can form such fibrils. The fibrils are typically of the order of 10 
nm in width and often extend for several μm but can in principle be indefinitely 
long [1,2,20]. Amyloid formation in fact seems to be a rather ubiquitous feature 
of proteins. It is not just a few proteins that can form such structures. Many or 
even most proteins and peptides might be able to do so, even if they are unrelated 
to diseases [1,2]. In many ways amyloid formation resembles crystallization. 
Many proteins are known to be able to crystallize in their native fold [21]. That 
is a key fact that has been used historically to determine protein structure through 
X-ray crystallography [21,22]. A useful way of viewing amyloids is perhaps as a 
crystalline state of a non-native fold of proteins and peptides in which each 
peptide backbone is folded in a plane, rather than in the normal tertiary structure. 
However, amyloids are usually fibrillar and twisted, rather than extending 
indefinitely in all directions. Whether that is the true thermodynamically most 
6 
stable state, or if an extensive 3D crystalline state might be more favorable but 
kinetically inaccessible, is an open question. It has been proposed that an 
extensive 3D crystalline state is in fact the most stable structure [23,24]. This 
consideration becomes especially relevant in amyloid formation by short 
peptides, where it has been experimentally observed that the same peptide can 
form both fibrils and more extensive 3D crystals, with similar molecular packing 
[24-27]. Analogously, some non-peptide molecules are also known to readily 
form fibrillar crystals rather than extensive 3D crystals [28,29]. 
During the 1930s William Astbury (1898-1961) et al. did X-ray scattering 
experiments on denatured proteins [30-32]. Various types of structures were 
classified into so-called Į- and ȕ- forms [22], which are due to the content of Į-
helix and ȕ-sheet structures in the proteins, clarified by Linus Pauling et al. in the 
1950s [33,34]. Of particular interest in the context of amyloids, Astbury et al. did 
X-ray scattering on denatured egg albumin for which a structure that would 
become known as cross-ȕ was inferred [30,35,36]. These experiments could 
perhaps be considered the birth of the biophysical branch of the amyloid field 
because the cross-ȕ structure is the structure of amyloids (Figure 1.2). Parallel to 
the biophysical branch, diseases in which deposits referred to as “amyloid” were 
found in the human body had been describes already in the 1800s [37]. These 
deposits were named “amyloid” because they were originally believed to be 
carbohydrate-like in their chemical nature, but soon they were found to primarily 
be deposits of aggregated proteins rather than carbohydrates [37,38]. This can be 
considered the medical or clinical branch of the amyloid field. A connection was 
formed between the biophysical and clinical branches in the 1950s due to electron 
microscopy observations that amyloid deposits in diseased tissues are made of 
bundles of fibrils [39-42]. Based on X-ray scattering, these fibrils were identified 
to have the cross-ȕ structure [35,36,43-47]. In addition to so-called systemic 
amyloidosis, which are diseases where amyloid deposits are found in tissues 
throughout the body [2], connections were also made with neurodegenerative 
diseases, such as Alzheimer’s and Parkinson’s disease, where amyloid deposits 
can be found in the brain. For example, tentative links were developed between 
Į-synuclein, Parkinson’s disease, and amyloid fibrils [14,15,48-50]. Similarities 
between amyloids and prions were also noted [51]. The presence of proteins 
misfolded and aggregated into amyloid fibrils might lead to an auto-catalytic 
cascade. More and more protein of the same type is promoted into adopting the 
amyloid structure by the aggregates already present in the diseased tissue. That is 
one hypothesis for how diseases such as Alzheimer’s and Parkinson’s spread 
through the brain, once initiated [52]. 
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Figure 1.2. Schematic illustration of the typical structure of an amyloid fibril. (a) Amyloid fibrils are typically of the 
order of 10 nm wide and often extend for several μm. They are usually twisted. (b) Illustration of cross-ȕ structure, 
which is the defining feature of amyloids. Several long intermolecular ȕ-sheets are stacked next to each other. The 
structure has two characteristic periodicities. One is the separation between ȕ-strands within each ȕ-sheet and is 
about 0.47 nm. The other one is the separation between stacked ȕ-sheets and is typically about 1 nm. These 
periodicities give rise to corresponding diffraction peaks in X-ray scattering. The illustration shows parallel ȕ-sheets, 
but they could in principle also be anti-parallel. (c) Cross-sectional view of the fibril. In the case of long proteins, the 
peptide backbone is typically folded in a complex shape in the plane perpendicular to the fibril axis. This also further 
illustrates the origin of the roughly 1 nm separation between ȕ-sheets. 
One prominent research group in the field of amyloid formation by short peptides 
has been David Eisenberg et al. They have studied crystallization of small 
amyloidogenic peptides and coined the term “steric-zipper” to describe the 
structural principle by which amyloids are stabilized [26,27]. The basic feature 
of a steric-zipper is interdigitation of the side groups of two ȕ-sheets running next 
to each other. To form a stable amyloid structure, it is necessary that certain 
geometric constrains are fulfilled. Eisenberg et al. classified amyloid structures 
formed by short peptides into various categories, depending on their symmetries 
[20,27]. For example, the ȕ-strands in the ȕ-sheets that make up the amyloids 
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might be either parallel or anti-parallel, and the orientation of the ȕ-sheets facing 
each other can also vary [20]. The NACore peptide used for the work in this thesis 
has been previously characterized to some extent in 2001 in an in vitro cellular 
system [9], and later by the Eisenberg et al. group in 2015 when they determined 
a 3D crystal structure of the peptide [10]. 
Another very influential research group in the amyloid field has been Christopher 
Dobson et al. This group for example highlighted the idea that perhaps most 
proteins, and not only a few disease-associated ones, can form amyloids [53]. 
They have also been influential in the proposal that it is oligomeric intermediates 
during the amyloid formation process that are the primary toxic species for cells, 
rather than the final mature fibrils [54]. Still, some open questions exist on this 
issue. The mechanism by which amyloids might lead to neurotoxicity, and 
thereby play a key role in the associated diseases is still poorly understood. 
Several lines of thought exist [1]. Some have focused on how amyloids might 
lead to oxidative stress [55]. Others have focused on if and how interactions with 
lipid membranes could be a mechanism of toxicity [56,57]. Yet another line of 
thought is that amyloid formation might be a consequence rather than a cause of 
disease [58]. In this thesis the main line of investigation is how amyloids interact 
with lipids and lipid membranes. 
1.3 The NACore peptide 
As mentioned above, the NACore peptide is a fragment from the protein Į-
synuclein, which is an intrinsically disordered protein involved in Parkinson’s 
disease. More specifically, the fragment spans from residue 68 to 78 in the protein 
and has the sequence GAVVTGVTAVA (Figure 1.3). This is part of the NAC 
region, which is a mostly hydrophobic stretch of amino acid residues in the center 
of Į-synuclein and makes up the central part of Į-synuclein amyloid fibrils. In all 
experiments for this thesis, an uncapped form of the peptide has been used, 
meaning that the peptide had free amino (-NH2/-NH3+) and carboxyl (-COOH/-
COO-) ends. These are the so-called N- and C- terminals (or termini) of the 
peptide, and their charge depends on the pH of the sample (see chapter 3). Before 
the work for this thesis started, some things were already known about this 
peptide. In 2001 Bodles et al. [9] did a series of experiments with various 
fragments of the NAC region with the aim of identifying minimal fragments that 
still retained properties such as the ability to fibrillate and toxicity to cells. The 
NACore peptide fragment, referred to as NAC(8-18) in that study, showed an 
ability to form fibrils as seen by negative stain transmission electron microscopy 
after incubation in water for several days at 37 °C. It also showed some toxicity 
to cells in vitro based on a diphenyltetrazolium bromide (MTT) reduction assay. 
Based on circular dichroism spectroscopy, they also reported that the peptide had 
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a disordered structure in aqueous buffer, but that it adopted increasing amounts 
of ȕ-sheet structure upon addition of the organic solvent acetonitrile, known to 
promote ȕ-sheet formation [9]. 
 
 
Figure 1.3. The NACore peptide. (a) Chemical structure of the NACore peptide, which has the primary sequence 
GAVVTGVTAVA. (b) The packing of the NACore peptide in the crystal unit cell determined by Rodriguez et al. in 
2015 [10]. PDB ID: 4RIL, rendered with UCSF Chimera [19]. 
In 2015, Rodriguez et al. in the Eisenberg group coined the name “NACore” for 
the peptide and confirmed its ability to form fibrils as well as its cytotoxicity in 
vitro [10]. In addition, they could find small 3D crystals of NACore in samples 
of the peptide dispersed in water (invisible by normal light microscopy). By using 
electron diffraction, they determined the structure of these crystals with atomic 
resolution (Figure 1.3b). That NACore crystal structure was then used to propose 
a molecular structure for amyloid fibrils of full-length Į-synuclein, which was 
unknown at the time. However, soon after that, reports of the structure of full 
length Į-synuclein amyloid fibrils based on nuclear magnetic resonance (NMR) 
and cryo-TEM appeared, showing that the structure is rather different, and also 
that it exhibits polymorphism [59-62]. There is perhaps no fundamental 
difference between fibrils and small crystals of the NACore peptide. Rather, it 
could be a matter of aspect ratio, which could depend on kinetic factors during 
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the formation process such as the growth rate of the various crystal faces. As was 
mentioned in the previous section, fibrillar or “needle-like” crystals are quite 
common also for non-peptide molecules. In Paper I of this thesis we studied 
NACore using pH as a tool to control its aggregation and fibrillation. That served 
to further establish NACore as a useful amyloid model peptide. Following that, 
we investigated its interaction with lipids in Paper II-IV. 
1.4 Lipids and cell membranes 
Although proteins play a very prominent role in the biological environment, they 
are not the only type of biomolecules present. In addition to countless small 
molecules, there are other macromolecules such as nucleic acids and 
carbohydrates. Lipids are another very prominent type of biomolecules [3]. One 
of the major roles of lipids in cells is to make up the basis of the cell membranes 
in the form of lipid bilayers. These are the “skins” of the cells and are present 
both on the outer surface and internally (in eukaryotes), where they are part of 
organelles. These bilayers are primarily made of lipids known as phospholipids, 
which typically have a polar headgroup on which two hydrocarbon chains are 
attached (Figure 1.4). In many organisms such as humans, lipids also act as an 
energy reserve in the form of fatty deposits [5,63]. Especially in neural tissues 
such as in brains, lipids are an important component. The function of brains is 
based on “lipid-rich wires” in the form of axons and dendrites. The connections 
between these wires, the synapses, are also lipid-rich structures and in addition 
depend on trafficking of synaptic lipid vesicles for signal transduction [64]. Lipid 
membranes are semipermeable barriers that control the transport of molecules in 
and out of cells, as well as internally between different compartments within the 
cells. The semipermeable nature of the lipid membranes arises from a 
combination of the intrinsic physicochemical properties of the lipids such as their 
hydrophobicity, and the presence of membrane proteins embedded in the bilayers 
that often act as channels for specific molecules. Disturbance of membrane 
integrity is one potential mechanism of toxicity for cells [56,65,66]. 
In vitro, phospholipids can form vesicles that can be used as model systems to 
capture some of the properties of real cell membranes [67] (Figure 1.4a). Due to 
their relative simplicity, their behavior can be more easily understood from a 
physicochemical perspective than what is the case with real cellular structures in 
living organisms. Knowledge of how lipids form vesicles in vitro, and details 
about cell membranes, are things that have developed a lot in the latter half of the 
1900s. In 1965 a paper was published on swollen phospholipid lamellae, which 
became important for the usage of giant vesicles as model systems for lipid 
membranes [68,69]. In the 1970s the so-called lipid mosaic model of biological 
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cell membranes was introduced [70]. At its core, it is still the main conceptual 
framework for the structure of cell membranes today. 
 
 
Figure 1.4. Lipid structures. (a) Schematic cross-sectional illustration of a small phospholipid vesicle. The vesicle is 
made up of a spherical lipid bilayer. Typically, a phospholipid bilayer is about 5 nm thick. (b) Chemical structure of 
two phospholipids called POPC (1-palmitoyl-2-oleoyl-glycero-3-phosphocholine) and POPS (1-palmitoyl-2-oleoyl-
sn-glycero-3-phospho-L-serine). (c) Example of a fatty acid. The chemical structure of linoleic acid (LA) is shown, 
which was used in experiments for Paper IV of this thesis. 
An important part of the self-assembly of lipids in aqueous solutions is 
hydrophobic interaction [71]. Due to the effective interfacial free energy with 
surrounding water, non-polar parts of molecules like lipids associate with each 
other in such a way that the exposure towards water is reduced. The exact 
structure of the lipid self-assemblies depends on factors such as the shape of the 
lipids. One approach to rationalize the various structures formed is based on 
considering the so-called lipid packing parameter [72,73] of the lipid molecules, 
which can be considered as a measure of how cone-shaped a lipid molecule is. 
Lipids with a low packing parameter form self-assemblies such as spherical 
micelles, and with progressively higher packing parameters the lipids self-
assemble into structures such as cylindrical micelles, bilayers and bicontinuous 
structures, and inverted micelles [72,73]. The effective packing parameter of lipid 
molecules can be influenced by factors such as the temperature, ionic strength, 
and pH of the surrounding solution. For example, changes in pH alters the 
chemical structure of some molecules by protonation and deprotonation, which 
results in variations in the number of charges on the molecules and thereby their 
interactions. For example, the self-assembly of fatty acids (Figure 1.4c) depends 
a lot on the pH. At high pH when the carboxyl group on the fatty acid molecules 
is deprotonated, they form micelles, and at intermediate pH when the molecules 
are partially protonated, they can assemble into bilayers that form vesicles. At 
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low pH, when essentially all molecules are protonated, a macroscopic oil-phase 
is instead formed. This was for example utilized in Paper IV. 
1.5 Amyloid-lipid interactions 
Disruption of lipid structures in the biological environment is considered as one 
potential mechanism by which amyloids can cause pathology [65,66]. Amyloid 
deposits in diseased tissues, such as Lewy bodies in Parkinson’s disease, have 
been found to contain lipids in addition to protein [74]. An early X-ray scattering 
study from 1969 of amyloid deposits from diseased spleen tissue also revealed 
evidence of lipids present in the aggregates [43]. During the last decades there 
has been a substantial amount of in vitro studies investigating the interaction 
between amyloids and lipids, both in terms of structure and kinetics. For example, 
amyloid forming proteins such as Į-synuclein and islet amyloid polypeptide 
(IAPP), which is involved in type 2 diabetes, have been found to co-localize with 
giant phospholipid vesicles and either disrupt or distort the membrane structure 
[75,76]. Distorted vesicles have also been observed with electron microscopy in 
the presence of amyloid fibrils of proteins such as ȕ2 microglobulin, IAPP, and 
Į-synuclein, and could also be linked to vesicle disruption [77-79]. 
Overexpression of Į-synuclein in a yeast model system has been reported to 
induce clustering of cytoplasmic vesicles, although not necessarily due to 
amyloids [80]. Mixed amyloid-lipid co-assemblies forming on molecular levels 
might also exist, such as in the case of Į-synuclein aggregated in the presence of 
the phospholipid DMPS (1,2-dimyristoyl-sn-glycero-3-phospho-L-serine) or 
DLPS (1,2-dilauroyl-sn-glycero-3-phospho-L-serine) [81]. Furthermore, it has 
been proposed that pre-fibrillar oligomers can form pores that insert in cell 
membranes and permeabilize them [65]. That is similar to the mechanism of 
action of some naturally occurring anti-microbial peptides [82]. 
In terms of kinetics, lipids of various types have been found to either accelerate 
or inhibit amyloid formation, depending on the conditions [83-86]. For example, 
anionic phospholipid membranes have been reported to accelerate Į-synuclein 
fibrillation by primary nucleation [85], and amyloid formation by the protein 
amyloid-ȕ, involved in Alzheimer’s disease, has been reported to be inhibited by 
the presence of zwitterionic membranes in a solid state [86]. At first, the literature 
can seem quite confusing, with a mixture of both accelerating and inhibiting 
effects on amyloid formation by lipids. However, when factors such as lipid-
protein ratio, lipid composition, and state of the lipid membranes (fluid or solid) 
are considered more carefully, the results can be rationalized to some extent. For 
example, some amyloid forming proteins are known to adsorb to lipid membranes 
of certain compositions, such as Į-synuclein which binds to anionic membranes. 
At intermediate lipid-protein ratios, both bound and unbound protein molecules 
13 
are expected to be present, and the interaction between the protein molecules in 
the two states could induce nucleation at the membrane interface [85,87]. In the 
case of a very high lipid-to-protein ratio, essentially all protein molecules might 
be sequestered by adsorption to the membranes so that the result is inhibition 
rather than acceleration of amyloid formation [83,85]. Furthermore, solid lipid 
membranes might reduce the flexibility of bound protein molecules, or the 
propensity of the protein molecules to bind to the membranes, and thereby reduce 
nucleation relative to the case with a fluid membrane [88,89]. 
Many of the questions about NACore-lipid interactions addressed in this thesis 
are inspired by these studies on other amyloid systems. Some questions that are 
addressed are: Does NACore co-aggregate with lipids (Paper II)? Does the 
presence of lipids result in formation of novel peptide-lipid mixed structures on 
a molecular level (Paper III)? How does the presence of lipids influence the 
kinetics of fibrillation (Paper III and IV)? 
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2. Methods 
2.1 Circular dichroism spectroscopy 
Light is electromagnetic fluctuations and molecules absorb light of various 
wavelengths depending on how the energy levels of their electric structures match 
up with the oscillations of the light [90]. In normal ultraviolet-visible 
spectrophotometry, light is passed through a sample and the attenuation of the 
transmitted light is measured for each wavelength, giving an absorption spectrum 
for the sample. In circular dichroism (CD) spectroscopy the fact that light can be 
polarized in various ways is utilized. More specifically, right and left circularly 
polarized light is used [91]. For non-chiral molecules, the interaction with these 
two polarizations of light are the same. However, when the molecules are chiral, 
as is the case of most biomolecules, the two polarizations are not equivalent. This 
is the key fact utilized in CD spectroscopy. The difference in absorption of right 
and left circularly polarized light is measured, either directly by alternating the 
polarization of the light used or indirectly through the so-called ellipticity of the 
light [91]. In the case of peptides, the difference in absorption between left and 
right circularly polarized light vary as a function of wavelength depending on the 
secondary structure of the peptides. The CD spectrum has a characteristic shape 
for each secondary structure, such as for Į-helices, ȕ-sheets, and random coils 
(Figure 2.1). CD spectroscopy can therefore be used as a method to get 
information about the structure of peptides and proteins in a sample [91]. If the 
sample contains molecules with different secondary structures, or if each peptide 
or protein consists of a mixture of various secondary structures, the CD spectrum 
is a superposition of these. It is possible to separate the different contributions 
through a linear decomposition of the spectrum, or through comparison to a 
reference database with the spectra of various known proteins [92]. 
This technique is useful for following the formation of amyloid fibrils. In the case 
of the NACore peptide studied for this thesis, the peptide molecules first have 
disordered structures. Then, after the fibrillation process has started, more and 
more of the peptide molecules in the sample adopt ȕ-sheet structures as they 
become part of fibrils. This can be clearly seen in the transformation of the CD 
spectrum (see for example Paper I). However, one complication with this 
technique is that it is not ideal if the sample contains macroscopic aggregates, as 
it might lead to distortions of the spectrum due to scattering effects, or flattening 
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of the curve due to heterogeneous absorption [93,94]. For example, the last effect 
occurs when there is highly absorbing material heterogeneously distributed in the 
sample so that some of the irradiating light does not hit many of the aggregates, 
whereas in other parts of the sample it hits much of the highly absorbing material 
and is substantially attenuated before it has gone through all of it. 
 
 
Figure 2.1. Illustration of characteristic CD spectra shapes for different secondary structures of proteins and 
peptides. The gray line shows a typical spectrum for disordered structures (random coil). The yellow dashed line 
shows a typical spectrum for ȕ-sheets, and the blue dotted line shows a typical spectrum for Į-helices. 
2.2 Static scattering 
Spatial structure can be represented in “real-space” as we are used to, or 
alternatively in so-called “inverse-space”. Mathematically, a Fourier transform 
can be used to convert from real space to inverse space, and this is at the core of 
how static scattering methods provide structural information about a sample [95]. 
The measurements are typically based on the scattering of X-rays, visible light or 
neutrons when passing through a sample. Different parts in the sample have 
different propensities to interact with the incoming radiation. This is known as 
scattering length density and gives rise to the contrast. In the case of X-rays, the 
scattering length density is proportional to the electron density in the sample. In 
the case of neutrons, it is due to a property of the atomic nuclei and varies in a 
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seemingly irregular way across elements [95]. Strong scattering at a detector 
occurs when there are differences in the scattering length density between 
different parts of the sample [95]. It occurs because re-emitted radiation from 
different parts of the sample interferes with itself either constructively or by being 
canceled out as it reaches the detector. Each point on the detector can be 
represented by a so-called scattering vector (q-vector). The scattering vector is 
the difference between the wave vector of the scattered and irradiating radiation 
[95,96] (Figure 2.2). At large angles, the scattering vector is large and gives 
information about high spatial frequency structure in the sample. At low angles, 
the scattering vector is small and gives information about low spatial frequency 
structure. The magnitude of the scattering vector also depends on the wavelength 
of the radiation used in the scattering experiments (Figure 2.2). The 
relationship between the real-space structure in the sample and the scattering 
intensity on the detector at a constant distance from the sample can be described 
by the equation 
ܫሺݍԦሻ = ܿ ڄ ห׬൫ɏሺݎԦሻ ڄ ݁ି௜ڄ௤ሬԦڄ௥Ԧ ڄ ݀ݎԦ൯หଶ, 
where ܫሺݍԦሻ is the intensity at the detector, ݍԦ is the scattering vector, ܿ is a 
proportionality coefficient, ɏሺݎԦሻ is the scattering length density distribution in the 
sample, ݎԦ is the position in the sample expressed as a vector from an arbitrary 
origin, and the integral denotes summation over the irradiated sample volume. 
This means that the scattering intensity is a section of the magnitude squared of 
the Fourier transform of the real-space sample structure. The scattering vector 
tells which part of the Fourier transform is probed. As hinted by the equation, one 
limitation of the structural information obtained with static elastic scattering is 
that the phase of the scattered radiation is normally lost at the detector (the so-
called phase problem) [95]. This means that some structural information from the 
sample is also lost, and what is obtained is essentially only the auto-correlated 
real-space structure, rather than the complete structure in the sample. 
As mentioned, scattering measurements can be done with several types of 
radiation, such as visible light, X-rays, neutrons, and electrons. In the case of 
visible light and electrons, the scattered radiation is easy to steer using lenses 
(magnetic lenses in the case of electrons). Therefore, structural information with 
light and electrons can also be obtained through microscopy (see below), which 
more directly gives a view of the sample structure. 
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Figure 2.2. Schematic illustration of a typical static scattering experiment. Radiation (such as X-rays or neutrons) is 
coming from a source as a narrow beam towards the sample. In the sample the radiation interacts with the sample 
material and is scattered. The transmitted and scattered radiation from the sample then hits a detector that records 
the intensity at different scattering angles, Ʌ. ݍԦ is the so-called scattering vector, ݇ ௦ is the wave vector of the scattered 
radiation, and ݇௜ is the wave vector of the incoming radiation. ɉ is the wavelength of the radiation. 
2.3 Light microscopy and fluorescence 
Light microscopy is one of the most traditional techniques used to get structural 
information on small scales. As the light is shining through the sample, the objects 
in the sample scatter the light based on differences in refractive index. In addition, 
different parts of the sample absorb the light to different degrees, especially if the 
sample has been dyed. A series of optical lenses focuses the light from the sample, 
which gives rise to a magnified image [97]. With ordinary bright field light 
microscopy, the contrast in the sample can be rather poor. Fluorescence is one 
physical phenomenon that can be utilized to enhance the contrast of the image, 
as well as to specifically label parts of interest in the sample. Molecules consist 
of atomic nuclei surrounded by electrons. If the frequencies are right, incoming 
electromagnetic waves that make up light can excite the electrons into higher 
energy states in the molecules [90,97]. For organic molecules that contain 
electrons dislocated over many atoms, the resonance frequencies are often in the 
range of visible light. When such electrons have been excited, they then 
eventually relax back to a lower energy state and might emit light in the process. 
This normally happens in several steps through a series of energy states, which 
results in that the emitted radiation is of a lower frequency than the radiation that 
exited the electrons, which in turn leads to a red-shift of the emitted light relative 
to the exciting light. This is the basis of fluorescence [90,97]. By using a set of 
filters in the microscope, the exciting light can be filtered away so that only the 
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fluorescently emitted light is detected [97]. The labeled components in the sample 
then stand out against a dark background in the microscopy images. 
There is a fluorescent dye called thioflavin T that can be used as a probe for 
amyloids (Figure 2.3). It is not fully understood in detail what the mechanism is 
by which thioflavin T can be used as a probe for amyloids, but a common 
explanation is as follows. Thioflavin T is a molecule with two parts that can rotate 
relative to each other when the molecule is free in solution. This rotation can 
dissipate energy when the molecule has been excited by incoming light, and 
thereby prevent strong fluorescence. When the molecule binds to an amyloid 
fibril by intercalating among the stacked ȕ-sheets, the rotation in the thioflavin T 
molecule becomes hindered and the fluorescence greatly increased [98]. Fibrils 
of NACore can for example be visualized in fluorescence microscopy by the 
presence of thioflavin T, which binds to the fibrils (Paper II). 
 
 
Figure 2.3. Chemical structure of thioflavin T, which is a fluorescent dye often used as a probe for amyloids. In the 
presence of amyloids, the fluorescence of the dye usually becomes greatly enhanced. The typical excitation peak 
of thioflavin T in the presence of amyloids is about 450 nm and the emission peak about 485 nm. 
One drawback of light microscopy is that the spatial resolution that can be 
achieved is limited by the wavelength of the light used (fundamentally by the 
same principle as how the size of the scattering vector determines the resolution 
in scattering methods). In practice this means that the highest resolution that can 
typically be achieved with an ordinary light microscope is about 0.2 μm, a little 
bit larger than the size of a typical virus particle [3]. This is far from the atomic 
and molecular scales we are often interested in. For example, the size of a 
stretched out NACore peptide molecule is about 3.6 nm, or 0.0036 μm. 
2.4 Confocal laser scanning microscopy 
Confocal laser scanning microscopy is a special kind of light microscopy. Rather 
than illuminating the entire sample, a laser is focused to a single focal point and 
is then moved along the sample to “scan” the entire sample area [97]. In the 
microscope there are pinholes which are arranged in such a way that they exclude 
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light from regions that are outside of the focal plane. This leads to that only a 
single focal plane is imaged at a time [97]. This is different from ordinary light 
microscopy where the focused light from the focal plane is mixed with unfocused 
light from other planes in the sample. A confocal laser scanning microscope 
typically uses fluorescently labeled samples to visualize the structure. The way a 
confocal microscope works also enables somewhat higher spatial resolution than 
an ordinary light microscope [97], although in principle the same limitation of 
spatial resolution due to the wavelength of the light used still remains. However, 
it should be mentioned that there are special tricks, based on fluorescence, that 
can be used to enhance resolution by up to about an order of magnitude. These 
are the so-called super-resolution microscopy techniques [99] and they were 
awarded a Nobel prize in 2014. One drawback of confocal microscopy is that the 
scanning of a sample point-by-point is often relatively slow, which means that 
the temporal resolution is typically rather poor. In other words, it is difficult to 
image objects that move around, because it leads to motion blur. 
2.5 Cryogenic electron microscopy 
As mentioned above, light microscopy has a limited spatial resolution due to the 
relatively large wavelengths of visible light. However, due to the wave-particle 
duality of matter, many other types of radiation with shorter wavelength can be 
utilized to obtain much higher spatial resolutions. One such form of radiation is 
a stream of electrons. Their wavelength depends on their kinetic energy and can 
easily be made to be fractions of a nanometer. This is what is utilized in electron 
microscopy. There are two main types of electron microscopy. One is so-called 
scanning electron microscopy (SEM) and the other one is so-called transmission 
electron microscopy (TEM). In the work for this thesis, TEM is the type of 
electron microscopy that has been utilized. In principle, TEM is very similar to 
normal light microscopy except that the light has been replaced with a stream of 
electrons accelerated by an applied voltage, and that the normal optical lenses 
have been replaced by magnetic lenses which are capable of steering the 
electrically charged electrons. The electrons hit the sample and are scattered or 
absorbed by different parts of the specimen. The electrons coming thought the 
sample are then focused by the magnetic lenses onto a detector to create a 
magnified real-space image of the structure in the sample [100]. 
One special type of TEM is so-called cryogenic transmission electron microscopy 
(cryo-TEM). In cryo-TEM a thin film of a sample that has been placed on a 
sample grid is very quickly frozen down to typically less than -150 °C. This quick 
freezing, or vitrification, is so fast that the sample solidifies without having time 
to substantially rearrange its structure (such as by crystallization) [101]. The 
vitrified sample is then transferred to the electron microscope and imaged at low 
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temperature. This means that a snapshot of the otherwise dynamic structure in the 
sample can be obtained with cryo-TEM. This technique was awarded a Nobel 
prize in 2017. With cryo-TEM, spatial resolutions down to a few nanometers can 
easily be achieved. If a sample contains a lot of identical objects, the spatial 
resolution can be brought down to an atomic level by calculating the average of 
many images [102]. One drawback of cryo-TEM is that the electron radiation 
rather quickly damages the sample, so that there is a limit to how many electrons 
that can be used to image it [101,102]. Another limitation is that it only gives 
gray-scale images. The selective labeling of different components of a sample is 
not as straightforward as in fluorescence microscopy, for example. 
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3. Summary and discussion of 
results 
3.1 Controlling self-assembly through pH 
The pH of a solution is an indirect measure of the chemical potential of hydrogen 
ions (protons). In dilute aqueous solutions relatively close to neutral pH, this is 
very closely related to the hydrogen ion concentration (or rather H3O+ 
concentration) by the equation 
݌ܪ = െ logଵ଴ ቀሾுశሿଵெ ቁ, 
where ሾܪାሿ is the hydrogen ion molar concentration. 
Many molecules have sites with loose protons, and pH affects the degree to which 
such protons are dissociated. In the case of the NACore peptide, the N- and C- 
terminal sites can be either protonated or deprotonated depending on pH (Figure 
3.1). Close to neutral pH the peptide is zwitterionic with a net charge of zero. If 
the pH is increased the N-terminus becomes deprotonated, and the peptide 
becomes net negatively charged. That net charge is also associated with an 
increased water solubility. This can be utilized to control the self-assembly of the 
NACore peptide (Paper I) (Figure 3.1). NACore can be dissolved at a high pH, 
after which fibrillation can be induced by lowering the pH towards neutral 
conditions where the peptide solubility is lower. This leads to a fibrillation 
process that typically extends over several days, and the progress can be followed 
by CD spectroscopy. The formed fibrils can be visualized by cryo-TEM. 
The NACore peptide is far from the only molecule for which the self-assembly 
can be controlled by pH. Another example is fatty acids, which can adopt 
structures varying from micelles, through vesicles, to oil droplets. This was for 
example utilized in Paper IV. 
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Figure 3.1. Charge of the NACore peptide as a function of pH. The protonation state of the N- and C-termini of 
NACore depend on the pH of the sample. At around neutral pH the peptide is zwitterionic (expected pI about 5.5). 
At high pH, the N-terminus becomes deprotonated and the peptide aquires a net negative charge. At low pH, the C-
terminus becomes protonated and the peptide acquires a net positive charge. NACore can be dissolved at high pH 
in aquous solutions. By then lowering the pH towards the isoelectric point fibrillation can be induced. 
3.2 NACore fibril structure 
The self-assembly of NACore through the procedure described above leads to the 
formation of fibrils that are typically several micrometers long, and typically ten 
or a few tens of nanometers wide (Figure 3.2). Through X-ray scattering it can be 
observed that two prominent diffraction peaks are present, corresponding to 
periodicities of about 0.47 and 0.85 nm, which is consistent with a cross-ȕ 
packing of the peptide molecules in the fibrils as is expected for amyloids [10,20] 
(Paper I). However, when the fibrils have not been aligned the diffraction peaks 
appear as isotropic circles, rather than as equatorial and meridian arcs as would 
have been the case with oriented fibrils. Several weaker diffraction peaks can also 
be detected which are consistent with the NACore 3D-crystal structure that has 
been reported by Rodriguez et al. [10], suggesting that the organization in the 
fibrils is similar to that structure (Figure 3.3). From electrostatic arguments and 
from comparison with literature [10,20], we assume the basic building block of 
the fibrils to be a “sandwich” of two long parallel ȕ-sheets facing each other. 
Interestingly, very wide fibrils can sometimes be observed and a striped pattern 
across the fibrils resolved (Figure 3.4). The separation between those stripes is 
the same as a stretched out NACore peptide molecules (3.6 nm) and suggests that 
a prominent feature in the fibril structure is terminus-to-terminus packing of the 
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peptide (Paper I) (Figure 3.5). The terminus-to-terminus packing is likely enabled 
by the short nature of the NACore peptide, which makes the terminal sites a major 
feature of the peptide and also keeps them exposed. Larger amyloid forming 
proteins and peptides often fold onto themselves in complex ways in the amyloid 
fibrils, which might make the terminal sites less accessible. 
 
 
Figure 3.2. Cryo-TEM image of NACore fibrils. The fibrils are typically ten to a few tens of nanometers wide and 
several μm long. Occasionally, a few twists can be observed but they do not occur regularly. (Paper I.) 
Another morphological feature of the NACore amyloid fibrils is their apparent 
lack of regular twisting. Normally, amyloid fibrils are twisted, presumably due to 
the chiral nature of the building blocks [103]. A twist to some degree is expected 
for long fibrillar objects in the generic case and is observed in many other systems 
(such as actin fibrils, microtubules, and DNA). It is also a possible explanation 
for why amyloids do not extend indefinitely in width [104,105]. In Paper I we 
suggest that the lack of twisting of the NACore fibrils could be due to stringent 
geometric constraints that have to be fulfilled when several ȕ-sheet sandwiches 
interact with terminus-to-terminus peptide contact. A similar result can be found 
in a recent simulation study of a short amyloid forming peptide [106]. 
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Figure 3.3. Small- and wide-angle X-ray scattering (SAXS and WAXS) of fibrillated NACore. (a) The SAXS pattern 
shows a characteristic slope at low q-values and a transition to a steeper slope around 0.3 nm-1, which gives 
information about the cross-sectional dimension of the structures. A small broad peak can be observed at a q-value 
corresponding to a periodicity of 3.6 nm, which is the same as the length of a stretched out NACore peptide molecule. 
(b) The WAXS pattern shows several diffraction peaks that are consistent with the crystal structure of NACore 
determined by Rodriguez et al. [10]. The inset shows the pattern on the detector (solvent subtracted). (Paper I.) 
 
Figure 3.4. Cryo-TEM image of a very wide NACore fibril. A striped pattern can be observed along the width of the 
structure. The separation between the stripes is 3.6 nm, as revealed by the position of the bright spots in a 2D 
Fourier transform of the image. This separation is consistent with the small marked diffraction peak in Figure 3.3a 
and matches the length of a stretched out NACore peptide molecule. (Paper I.) 
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Figure 3.5. Different ways of packing sandwiched ȕ-sheets. The blue and red dots represent the N- and C-termini 
of the NACore peptide. The arrows show the long axis of fibrils (a) Terminus-to-terminus packing, which seems to 
be what typically makes up the widths of NACore fibrils based on cryo-TEM (see for example Figure 3.4 and 3.7). 
(b) Face-to-face packing. (Paper I.) 
3.3 Aggregation versus fibrillation 
In the case of condensation of a gas (or dilute solution) into a dense liquid, as 
well as in the case of crystallization, the concept of nucleation applies. For 
example, when a gas such as steam is condensing into liquid water in response to 
a change in external conditions, small initial clusters of the liquid are usually 
thermodynamically unstable due to a relatively large surface-to-volume ratio 
compared to an infinite bulk-phase. It is necessary that a certain minimum size is 
exceeded before the clusters become thermodynamically stable and can grow. 
Such minimal clusters are referred to as nuclei, and overcoming this initial barrier 
is a nucleation event [107,108]. In the case of crystallization such as the freezing 
of liquid water, the situation is in many ways analogous. However, in that case 
the system is already condensed, so the critical step that needs to take place is the 
formation of a sufficiently large cluster of ordered molecules, rather than an 
increase in density. When a system is brought directly from conditions in which 
a dilute state is the most stable to conditions in which a crystalline state is the 
most stable, the two types of events described above, condensation and ordering, 
might occur in sequence (and perhaps always does to some extent). This is known 
as two-step nucleation, which might be a common phenomenon and is found in a 
range of systems [107,109,110]. 
Since amyloid fibrils are highly ordered structures, principles like those of two-
step nucleation might apply to the fibrillation process [110] (Figure 3.6). If it is 
assumed that the initial state is a solution of peptide monomers, the first thing that 
needs to happen for a fibril to form is that several molecules come together in the 
solution. However, just coming together is not enough, because fibrils are highly 
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ordered. That means that the peptide molecules that have come together also need 
to adopt an order that is compatible with fibril formation and subsequent 
elongation. In principle, the initial association, or the aggregation step, and the 
adoption of an ordered structure could be separate processes. With the NACore 
peptide we found some evidence for such behavior in the sense that lowering the 
pH closer to the isoelectric point of the peptide led to slightly slower rather than 
faster fibril formation. If fibrillation only involved association into a dense 
structure, lowering the pH closer to the isoelectric point of the peptide might have 
been expected to result in faster fibrillation, due to a reduced peptide solubility 
(higher supersaturation) and thereby a larger overall tendency to aggregate. In 
addition, we observed small clusters attached to fibrils in the lower pH condition 
(Paper I) (Figure 3.7). Close to the isoelectric point, conversion to highly ordered 
structures might be slower than at higher pH, counteracting the otherwise 
expected faster fibrillation based on solubility and supersaturation alone. The 
observed clusters could be kinetically transient peptide aggregates that have not 
yet adopted the molecular order found in the fibrils. Conceptually similar 
behavior has also been reported in other amyloid systems [111-113]. 
 
 
Figure 3.6. Schematic illustration of a two-step fibrillation process. In step 1 peptide molecules come together and 
form dense clusters. In step 2 the peptide clusters obtain an ordered structure and grow into fibrils. 
Clusters attached along the sides of fibrils could also be relevant to mechanisms 
of secondary nucleation [114]. Secondary nucleation in the context of amyloids 
is the catalysis of new fibril nuclei by the presence of fibrils that have already 
formed and leads to an auto-catalytic cascade of fibrillation [115]. Catalysis of 
nucleation could for example occur through local enrichment of monomers on the 
fibril surfaces by adsorption from solution and/or through catalyzed structural 
conversion of non-fibrillar clusters upon contact with the fibrils. 
 
29 
 
Figure 3.7. Example of clusters seen along the side of an NACore fibril (arrows) after unfibrillated peptide was added 
to a small amount of preformed fibrils at pH 6. A striped pattern is also seen across the fibril (like the one in Figure 
3.4). The width of the fibril changes in the middle of the images, which might give clues about growth mechanisms. 
The inset shows a schematic interpretation of the structure in the cryo-TEM image. (Paper I.) 
3.4 NACore fibrils as colloidal objects 
As mentioned above, the NACore fibrils are typically only about ten or a few tens 
of nanometers wide. In other words, they have colloidal-scale cross-sections and 
can be considered as colloidal objects [73]. This is important to consider when 
investigating the interaction of NACore fibrils with other molecules such as lipids 
because the colloidal dimensions of the fibrils open up for a new type of 
interaction mode to become dominant, namely interfacial interactions. For 
example, a cubical structure that is 1 mm on each side has a volume of 1 mm3 
and the total surface area is 6 mm2. If the same total volume is divided up into 
1013 fibrils that have a 10-by-10 nm square cross-section and are 1 μm long, the 
total surface area becomes 402 000 mm2. In other words, the extent of potential 
interfacial interactions is very much larger for colloidal objects compared to 
macroscopic ones of the same total volume. Instead of interactions with other 
molecules mainly in the bulk parts of the structures, interactions through 
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interfacial affinities become significant, as might be the case for NACore-lipid 
interactions (see below, and Paper II-IV). 
3.5 Co-aggregation with phospholipid vesicles 
One potential mechanism by which amyloid formation might induce cell toxicity 
is by disruption of lipid membrane structures and functions [65,66]. That is one 
motivation for why it is interesting to know how amyloid fibrils interact with 
lipids. By using fluorescence microscopy, we found that when NACore peptide 
is fibrillated in the presence of giant phospholipid vesicles, the vesicles become 
captured within the gel-like NACore amyloid fibril networks (Paper II) (Figure 
3.8). In these experiments, NACore was incubated in the presence of the 
fluorescent thioflavin T probe for amyloid fibrils and fluorescently labeled giant 
phospolipid vesicles, so that the different components of the sample could be 
visualized. Also, when NACore had first been fibrillated in the absence of lipids 
and was then mixed with vesicles, they attached to the gel-like NACore fibril 
networks. This shows that the affinity between the vesicles and the fibrils is not 
crucially dependent on the fibrillation process itself. However, the fibrillation 
process might perhaps enhance disruption of vesicles, for example by free energy 
dissipation during the thermodynamically down-hill fibrillation. 
 
 
Figure 3.8. Co-aggregates of NACore fibrils (blue) and phospholipids (red) as seen with confocal fluorescence 
microscopy. NACore was fibrillated overnight in the presence of thioflavin T and fluorescently labeled phospholipid 
vesicles composed of a mixture of POPC and POPS. (a) Low magnification image of a co-aggregate. (b) High 
magnification image (not the same sample as in “a”). (Paper II.) 
Biological membranes in cells have different lipid compositions depending on 
where they are [116]. In addition, they have different types of membrane proteins 
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that confer particular functions to the membranes. One interesting thing to know 
is whether amyloid formation can scramble the composition of such different 
membranes. Disruption of their separate compositions, and consequently their 
distinct functions in the cellular environment, could be a potential mode of 
toxicity. We did experiments in which there were two populations of 
phospholipid vesicles. One population was labeled with a red fluorescent dye, 
and the other one was labeled with a green dye. Apart from the fluorescent dyes, 
the composition was the same. An equimolar mixture of these differently colored 
vesicles was co-incubated with NACore to see if the fibril formation would lead 
to scrambling of the membranes. It was found that NACore fibrillation did not 
induce total scrambling of the membranes (at least not after one day of 
incubation), because different regions of the co-aggregates retained their separate 
colors, rather than forming large areas of mixed (yellow) color as would be the 
case if total mixing of the bilayers had occurred (Figure 3.9). However, since 
most of the vesicles were multilamellar this might also reflect an inability of the 
NACore fibrils to penetrate beyond the outermost bilayer. Some of the single-
color regions were spread out into non-spherical shapes. That is an indication of 
distortion or disruption of the original vesicles (Paper II). 
 
 
Figure 3.9. Co-aggregates of NACore fibrils formed in the presence of two populations of phospholipid vesicles (red 
and green) seen with confocal fluorescent microscopy. Separate red and green regions can be seen in the 
aggregates, showing that the fibrillation process did not lead to extensive mixing of separate lipid bilayers. (a) Low 
magnification image. (b) High magnification (not the same sample as in “a”). (Paper II.) 
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3.6 Nanostructure of NACore-phospholipid co-
aggregates 
In the fluorescence microscopy experiments it was found that phospholipid 
vesicles co-aggregate with NACore fibrils on optical length-scales. However, 
light microscopy is insufficient for getting detailed structural information at 
nanometer length scales, which is the size domain of the cross-section of 
individual fibrils and of the phospholipid bilayers. To get information about how 
intimately the peptide and lipids are co-aggregated it is necessary to use 
additional techniques. One such technique is cryo-TEM. When NACore is 
fibrillated in the presence of phospholipid vesicles and imaged with cryo-TEM, 
trapped and distorted vesicles can be found attached to and interspersed in the 
fibrillar network (Paper III) (Figure 3.10). Especially in the case of zwitterionic 
vesicles with no net charge there were a lot of distorted bilayer structures (Paper 
III). Structurally distinct fibrillar and bilayer structures could, however, still be 
observed with cryo-TEM, suggesting that the fibrils and bilayers to a large extent 
retain their separate identities on nanometer length scales even after they have 
been co-aggregated. 
To get more structural information about this, X-ray scattering was used. X-ray 
scattering easily probes structures down to fractions of a nanometer. However, 
the structures detected with X-ray scattering are based on periodicities in the 
sample, which means that ordered structures are the ones primarily detected. 
When several independent structures exist in a sample, the X-ray scattering 
pattern is a linear combination (a sum) of the scattering from the individual 
components. One way to test how intimately the peptide and lipid components 
co-assemble is thus to test whether their X-ray scattering can be fitted as a linear 
combination of the separate components. If the X-ray scattering profile cannot be 
fitted as a linear combination, it is an indication of new co-assembled structures 
on molecular length scales. We found that the X-ray scattering from peptide 
fibrillated in the presence of phospholipid bilayers could be well fitted by a linear 
combination of the scattering from fibrils and bilayers, consistent with the 
conclusion that the fibrils and bilayers retain their separate structures on 
molecular length-scales when co-aggregated (Paper III) (Figure 3.11). However, 
the peptide fibrils and vesicles clearly have an affinity for each other, leading to 
their co-aggregation on large length scales as discussed before and as seen in 
cryo-TEM. The association between vesicles and fibrils is likely due to interfacial 
attractions, enhanced by the colloidal scale of the NACore amyloid fibrils which 
leads to a lot of exposed interfacial area (see Section 3.4). 
33 
 
Figure 3.10. Cryo-TEM image of NACore fibrillated in the presence of small unilamellar phospholipid vesicles 
composed of POPC and POPS. “F” is for fibrils and “V” is for vesicles. “C” denotes the cryo-TEM carbon grid. 
Trapped and highly distorted vesicles can be seen among the fibrils. The scale bar shows 200 nm. (Paper III.) 
 
Figure 3.11. SAXS and WAXS data for NACore co-incubated with phospholipid vesicles (POPC:POPS). (a) The 
main NACore WAXS diffraction peaks are unaffected by co-incubation with the lipids. (b) Co-incubated NACore and 
POPC:POPS can be fitted as a linear combination of fibrils alone and POPC:POPS alone. The data in “a” and “b” 
indicate that the nanometer-scale structure is mostly unaffected by co-incubation. (Paper III.) 
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In this and the previous section, interaction between NACore and phospholipids 
has been addressed. Instead of phospholipids, a fatty acid, linoleic acid, was used 
as an interaction partner in one of the studies for this thesis (Paper IV). There, the 
focus was mainly on fibrillation kinetics. In contrast, the focus in the papers on 
NACore-phospholipid interaction was mainly on structure, although Paper III 
includes some experiments and discussion about the effect of phospholipid 
vesicles on the kinetics of fibrillation as well. In future research it would be 
interesting to investigate structural aspects of the interaction between fatty acids 
and the NACore peptide (or other amyloid forming peptides and proteins) in more 
detail. Conversely, it would be interesting to further investigate the effects of 
phospholipids on the fibrillation kinetics, especially to find out if the mechanism 
of action is the same for both phospholipids and fatty acids. 
3.7 Inhibition of fibrillation by the presence of lipids 
We found that the presence of lipids inhibits NACore fibril formation. This was 
the case with phospholipids (Paper III) but was especially so with a fatty acid 
(linoleic acid) (Paper IV). Already at about 1 % of fatty acid by mass relative to 
the peptide mass in the sample, a substantial inhibitory effect could be observed 
(Paper IV). This inhibitory effect mainly manifested itself through a prolongation 
of the lag-phase of the fibrillation reaction (Figure 3.12). One hypothetical way 
in which the presence of lipids could inhibit fibrillation is by sequestering peptide 
monomers in the solution, which would essentially lead to a lower free peptide 
monomer concentration and thereby slower fibrillation due to a lower degree of 
supersaturation [108]. This was for example suggested in Paper III as an 
explanation for how phospholipid vesicles can inhibit NACore fibrillation. 
However, based on the experiments in Paper IV it is hard to imagine this as the 
main mechanism of action in the case with linoleic acid. That is because an 
inhibitory effect was observed already at a very low amount of the fatty acid (1 
% relative to peptide mass, or 0.00014 % relative to the total sample mass). 
Consequently, for the free peptide concentration to be substantially reduced it 
would be required that a lot of peptide monomers are sequestered for every lipid 
molecule and that the partition coefficient for the peptide between the lipid and 
aqueous phase is extremely large. Another, and probably more likely explanation, 
is that interaction mainly occurs between larger particles of each species. That 
makes sense from an interparticle interaction-potential point of view because the 
interaction-potential is generally amplified by increasing particle sizes [117]. As 
a simple example, the van der Waals interaction between two spherical particles 
at close distance to each other can be approximated by 
ܹ = ି஺଺ڄ஽ ڄ ோభڄோమோభାோమ, 
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where ܹ is the potential free energy, ܴଵ and ܴଶ are the radii of the two particles, 
ܦ is the separation between them, and ܣ is the so-called Hamaker constant [117]. 
As the radii increase, the interaction-potential also increases in amplitude by this 
relation. In the case of NACore-lipid interaction, the main driving force is likely 
hydrophobic rather than van der Waals forces, but also in that case the attractive 
interaction would become stronger the larger the particles are (due to increased 
interfacial areas for larger particles). In cryo-TEM images of NACore in the 
presence of linoleic acid, we could see rather large non-fibrillar structures among 
the fibrils (Figure 3.13). Those structures might consist of peptide clusters and 
fatty acid that have co-associated with each other. 
The explanation described above assumes that lipid-associated peptide clusters 
(non-fibrillar oligomers) are prevented from forming mature fibrils. If the fatty 
acid molecules are unable to fit in the highly ordered crystalline structure of the 
mature fibrils, they need to be excluded from the non-fibrillar peptide clusters 
before they can form the fibrils. This constitutes an entropic barrier and could 
potentially explain how lipid-associated peptide clusters are stabilized. The 
population of initial pre-fibrillar clusters might be very small relative to the total 
peptide concentration in the sample, but it is potentially an essential population 
in terms of what eventually gives rise to the fibrils. It could consequently be 
sufficient to sequester this small population of peptide clusters to hinder 
fibrillation. This could explain how a very small amount of additives, such as the 
fatty acid in Paper IV, can substantially inhibit or modulate fibrillation. In 
principle, a mechanism like the one outlined above could also explain the 
inhibitory effect of phospholipid vesicles on fibrillation of NACore, but that 
remains to be investigated in more detail. 
When comparing the inhibitory effect of linoleic acid on NACore fibrillation at 
two different pH, we found that it was much more potent at pH 6 than at pH 8 
(Paper IV). At pH 6, the net charge and solubilities of both the NACore peptide 
and linoleic acid are expected to be lower. From an argument based purely on 
solubility, we might consequently have expected aggregation to be faster at the 
lower pH. But as has been emphasized, amyloid formation is also about obtaining 
order. A lower pH likely leads to stronger attraction between the peptide and fatty 
acid due to reduced electrostatic repulsion, which thereby could result in more 
inhibition of fibrillation due to more peptide-lipid co-association. 
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Figure 3.12. Inhibitory effect of linoleic acid (LA) on NACore fibrillation, as seen with CD spectroscopy. The peptide 
concentration was 150 μM in all samples. (a) NACore without LA. A gradual transition from a disordered structure 
to a ȕ-sheet-rich structure can be seen over time, which indicates fibrillation. (b) 5 μM LA present in the sample. (c) 
20 μM LA present. (d) 80 μM LA present. With increasing concentrations of LA the fibrillation is inhibited. An effect 
is seen already with 5 μM LA. The insets show the composition of NACore (blue) and LA (red). The numbers and 
areas of the dots are proportional to the molar concentration and mass, respectively. (Paper IV.) 
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Figure 3.13. Cryo-TEM image of NACore fibrillated in the presence of linoleic acid (same sample composition as in 
Figure 3.12b). “F” denotes fibrils. In addition to fibrils, non-fibrillar structures can be seen attached to the fibrils 
(arrows). This might be clusters composed of a mixture of peptide and fatty acid. (Paper IV.) 
3.8 Full-length Į-synuclein 
The investigation of the NACore amyloid model system and its interaction with 
lipids has been the main focus of the work for this thesis. However, some work 
on full-length Į-synuclein has also been performed, with a focus on how it 
interacts with lipids (Paper V). There are some qualitative differences in the 
behavior of full-length Į-synuclein and the NACore peptide fragment. The N-
terminal region of Į-synuclein has a net positive charge at physiological pH and 
contains seven imperfect KXKEGV repeats (where X is a variable amino acid 
residue). This leads to adsorption of monomeric Į-synuclein to anionic 
phospholipid bilayers and the adoption of an amphipathic Į-helix in the N-
terminal part of the protein [118] (Paper V) (Figure 3.14). This is different from 
the behavior of NACore. For example, the CD spectrum of unfibrillated NACore 
is essentially identical in the presence and absence of phospholipid vesicles 
(Paper III). If monomeric NACore adsorbs to the phospholipid bilayers, it does 
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so in a disordered form similar to that in solution and leaves no trace of it in the 
CD spectrum. 
 
 
Figure 3.14. Monomeric Į-synuclein in the presence of phospholipid vesicles. (a) CD-spectra of Į-synuclein with 
increasing amounts of DOPC:DOPS anionic vesicles present. As the lipid-to-protein ratio increases, more and more 
Į-helix content is seen in the CD-spectra. (From Paper V.) (b) Fluorescence correlation spectroscopy (FCS) 
measurements of fluorescently labeled Į-synuclein in the presence of lipid vesicles with different compositions. FCS 
gives information about the diffusion rate of fluorescently labeled molecules (Į-synuclein in this case). Slower 
diffusion leads to curves shifted to the right, which happens in the presence of the anionic vesicles made of 
DOPC:DOPS and DOPC:GM1 (ganglioside). This indicates adsorption to the vesicles. With zwitterionic DOPC 
vesicles no major shift in the correlation curve is seen relative to Į-synuclein alone. (Unpublished data.) 
In Paper V we showed that anionic lipid vesicles can accelerate Į-synuclein 
amyloid formation and that the accelerating effect is slightly stronger for so-
called ganglioside lipids, which have large carbohydrate headgroups, compared 
to other anionic lipids. All anionic membranes led to partial Į-helical structure of 
Į-synuclein, presumably due to adsorption to the membranes (see for example 
Figure 3.14b). We also found that uncharged lipids with large headgroups might 
accelerate fibrillation to some degree, but much less so than anionic lipids. 
Furthermore, the large anionic headgroup of one of the ganglioside lipids could 
induce amyloid formation by itself, even without the rest of the lipid molecule, 
and without inducing Į-helical structure of Į-synuclein. Although ganglioside 
lipids led to slightly stronger acceleration, the results imply that the most 
important factor for acceleration is membrane charge. The fact that some species 
such as the free ganglioside headgroup also effectively induce fibrillation without 
inducing Į-helical structure of Į-synuclein implies that it is not strictly required 
as an intermediate state to promote Į-synuclein amyloid formation. 
The accelerating effect of some lipid membranes on Į-synuclein fibrillation 
differs qualitatively from the inhibitory effect on NACore fibrillation. One reason 
for this could be differences in adsorption behavior of monomeric Į-synuclein 
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and NACore to phospholipid bilayers, as discussed above. In addition, under 
quiescent conditions and with monomeric Į-synuclein alone, amyloid formation 
often does not spontaneously occur (see for example Paper V). This is different 
from the case with NACore under the conditions used in the experiments for this 
thesis, which readily lead to spontaneous fibrillation of the peptide. The presence 
of anionic lipid membranes is thought to induce Į-synuclein amyloid formation 
by heterogeneous primary nucleation on the membrane surface [85]. Such an 
effect would not be very noticeable with NACore since nucleation happens 
anyways under the conditions used. That could also be a reason why an 
accelerating effect was not observed. Three main factors that I think are important 
to consider when comparing the effect of lipids on fibrillation kinetics for various 
amyloid forming proteins and peptides are as follow. (1) Whether fibrillation 
occurs spontaneously in the absence of the lipids. (2) Whether the protein or 
peptide monomers adsorb to the lipid structures. (3) Whether adsorption of the 
protein or peptide to the lipid structures is coupled to a conformational change of 
the protein or peptide (see also the discussion in Paper IV). 
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Epilogue 
The biological environment is extremely complex, and we are still far from fully 
understanding it from a physicochemical perspective. In the work for this thesis 
a short peptide was studied to contribute to our understanding of amyloids, which 
are involved in many diseases related to old age. That topic is becoming 
increasingly relevant as people are living longer. Another reason for studying 
amyloids is simply that they are interesting from a basic science perspective. 
Furthermore, there could be technological applications. In terms of understanding 
biology in a broad context, the philosophy underlying this thesis is perhaps a bit 
like the one in the book “On Growth and Form” by D'Arcy Wentworth Thompson 
[119] but applied on a molecular level. By becoming familiar with the physical 
stage on which biology happens, features that have specific biological functions 
can be more easily recognized among non-evolved features that arise due to 
generic principles of physical chemistry. Some non-living things can indeed 
appear rather life-like on first sight (such as self-assemblies of lipids), even before 
they have been evolved by natural selection. 
Fundamentally, I think science is about creating models of the world. Many of 
the well-established “textbook” theoretical models in physical chemistry are 
about systems in equilibrium. However, many of the most interesting phenomena 
in the world occur out of equilibrium (such as living processes). The often very 
low solubilities of amyloids also often lead to very long equilibration times and 
consequently make kinetic aspects of the systems important. For example, the 
fibrillation of NACore typically extends over several days, and even then, the 
system might not reach its true thermodynamic equilibrium. In the absence of 
comprehensive theories, one way to test if the initial models you form in your 
mind really work as you think they do is to do computer simulations. This could 
be simple coarse-grained simulations, and I think it would be very useful to do 
this parallel to experiments as an intermediate step towards complete 
understanding. That is one of my suggestions for future research. In the long 
history of science, the possibility to easily do such simulations is only a few 
decades old, due to the quite recent rise of modern computers. 
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Fluorescent phospholipid vesicles trapped in a network of NACore 
amyloid fibrils. The scale bar shows 10 μm.
